Underutilization of anticoagulant for venous thromboembolism prophylaxis in three hospitals in Jakarta

Acta Med Indones. 2015 Apr;47(2):136-45.

Abstract

Aim: to assess the current use of anticoagulants and implementation of International Guidelines in venous thromboembolism (VTE) prophylaxis in hospitalized patients with acute medical illnesses in Jakarta, Indonesia.

Methods: a multicenter, prospective, disease registry, recruiting patients diagnosed as acutely ill medical diseases and other medical conditions at risk of VTE, with in-hospital immobilization for at least 3 days.

Results: of 401 patients, 46.9% received anticoagulants which included unfractionated heparin (64.4%), fondaparinux (11.7%), enoxaparin (9.6%), warfarin (3.7%), and combination of anticoagulants (10.6%). VTE prophylaxis using physical and mechanical method was used in 81.3% of patients, either as a single modality or in combination with anticoagulants. During hospitalization, VTE were found in 3.2% patients; 10 patients (2.5%) had lower limb events and 3 patients (0.75%) had a suspected pulmonary embolism. The main reference international guidelines used were AHA/ASA 2007 (47.4%), followed by ACCP 2008 (21.7%).

Conclusion: the study showed underutilization of prophylaxis anticoagulants in which mechanical thromboprophylaxis either alone or combination with anticoagulants was the most commonly used. Unfractionated heparin was the preferable choice. The most commonly used guideline was AHA/ASA 2007. VTE thromboprophylaxis in medically ill patients needs to be encouraged.

Publication types

  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Aged
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Drug Therapy, Combination
  • Enoxaparin / therapeutic use*
  • Female
  • Fondaparinux
  • Heparin / adverse effects
  • Heparin / therapeutic use*
  • Hospitalization
  • Humans
  • Indonesia
  • Male
  • Middle Aged
  • Polysaccharides / therapeutic use*
  • Practice Guidelines as Topic
  • Prospective Studies
  • Risk Factors
  • Venous Thromboembolism / prevention & control*
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Enoxaparin
  • Polysaccharides
  • Warfarin
  • Heparin
  • Fondaparinux